GovChime
AWARDDELIVERY ORDEROther than small business

Delivery order 75N91022F00002UNIVERSITY OF OKLAHOMA

Overview

Award facts

Net obligations
$1.44M
$1,435,788of $1.44M potential value
Outlays (paid to date)
$1.28M
$1.28M paid of $1.44M obligated$1,279,683
Period of performance
Aug 5, 2022 to Feb 4, 2027
Ends in 2 months
Modifications
3
Latest action Jan 13, 2026
Contract type
Delivery order
PIID 75N91022F00002

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE

Dates and value

Award date
Signed on Aug 2, 2022
Potential end of performance
Feb 3, 2027
Current value
$1,435,788Base and exercised options
Potential value (if all options are exercised)
$1,435,788
Parent contract vehicle
75N91019D00020 (IDC, multiple award) — 15 orders recorded under it

Obligations by fiscal year of action

  • FY2024: $389,694
  • FY2022: $1,046,094

Total across 2 fiscal years: $1,435,788

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jan 13, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationOKLAHOMA CITY, OK
UEIGY8NMUZQXVS7
CAGE code4B862
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeUS government entity

Business types and certifications

Educational institutionU.S. government entity

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NIH NCI
Funded from
National cancer institute (0849)Program activities075-0849Federal accounts (agency financial reports)

Place of performance

Place of performance
Oklahoma City, Oklahoma County, Oklahoma 73104-3609
Congressional district (place of performance)
OK-05As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Subject to multiple award fair opportunityMAFO
Set-aside
Not reported
Contract pricing
Firm fixed priceJ
Offers received
2

Solicitation and notices

Solicitation ID
TORFP 2022 E-04(as reported)
Solicitation date
Feb 18, 2022

Contract details

Subcontracting plan
Individual subcontract planF
Major program
Title: bladder cancer chemoprevention using the androgen receptor inhibitor apalutamide
Certified cost or pricing data
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Aug 2, 2022Base obligation at award: $1,046,094
Latest action
Jan 13, 2026 — Supplemental agreement (within scope)Modification P00003
Latest substantive action
Jan 13, 2026 — Supplemental agreement (within scope)Modification P00003
Actions by type
  • Base award1
  • Supplemental agreement (within scope)2
  • Change order1
4 actions recorded, Aug 2, 2022 to Jan 13, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
Bio-basedE
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Walsh-Healey Act (materials and supplies)
Yes

Place and origin

Domestic or foreign entity
Other U.S. entity (e.g. government)B
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Multiple awardM
Parent vehicle agency
National Institutes Of Health7529
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N910
Transactions recorded under this award key
4

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N910
Treasury accounts
  • 075-2022/2022-0849-000
Object classes
  • 25.1: Advisory and assistance services
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression